5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice-Reference-Cited by-同舟云学术

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice

Published:2017-03-15 Issue:11 Volume:42 Page:2163-2177
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Pogorelov Vladimir M,Rodriguiz Ramona M,Cheng Jianjun^ORCID,Huang Mei,Schmerberg Claire M,Meltzer Herbert Y,Roth Bryan L,Kozikowski Alan P,Wetsel William C

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp201752.pdf

Reference75 articles.

1. Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M et al (2009). Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci 29: 8156–8165.

2. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005). Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55: 242–251.

3. Aloyo VJ, Berg KA, Spampinato U, Clarke WP, Harvey JA (2009). Current status of inverse agonism at serotonin 2A (5-HT2A and 5-HT2C receptors. Pharmacol Ther 121: 160–173.

4. Alsiö J, Nilsson SR, Gastambide F, Wang RA, Dam SA, Mar AC et al (2015). The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study. Psychopharmacology (Berl) 232: 4017–4031.

5. Angrist B, Rotrosen J, Gershon S (1980). Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Berl) 72: 17–19.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists;Neuropsychiatric Disease and Treatment;2024-03

2. Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System;Brain Sciences;2024-01-05

3. Serotonin 2A Receptor (5-HT_2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants;Chemical Reviews;2023-11-30

4. Biological studies of clavine alkaloids targeting CNS receptors;Frontiers in Psychiatry;2023-11-21

5. NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia;Behavioural Brain Research;2023-10